Location: Home
  • search
  • go
  • Relate News
  • 11/11/2024Alphamab Reports Results of FIH Clinical Study of Anti-HER2 ADC and PD...
  • 11/11/2024NHSA and MOF Jointly Issue the Notice on Prepayment of BMI Funds
  • 11/11/2024China to Launch Pilot Programme for Virtual Primary Care Standards
  • 11/8/2024Junshi Reports on Phase II Trial of Toripalimab in Combo with Gemcitab...
  • 11/8/2024Pfizer Ignite Partners with Beijing Mabworks to Develop Novel MM Thera...
  • 11/8/2024Ping An Health and Medtronic Form Strategic Partnership at the CIIE
  • 11/8/2024Recent Executive Moves
  • 11/7/2024A Share-Listed Pharma Companies Report Solid Performance in Q3/2024
  • 11/7/2024Minghui Pharma Announces Promising Initial Results from Phase I Trial ...
  • 11/7/2024Aditum Bio and Leads Biolabs Forms JV Oblenio Bio to Develop a Tri-Spe...
  • 11/7/2024Stimulus Package vs. Drug Price Negotiation, Impacts on China's Health...
  • 11/6/2024NMPA Accepts AbbVie's BLA for Epcoritamab (Epkinly) for Lymphomas
  • 11/6/2024Pharma Firms Present Innovative Treatments for Major Diseases at CIIE
  • 11/6/2024MNCs and Chinese Partners Join Forces to Build an Innovative Healthcar...
  • 11/5/2024NMPA Solicits Public Comments on Drug Contract Manufacturing Document
  • 11/5/2024AstraZeneca China Updates Leadership and Ownership Structure Amid Inve...
  • 11/5/2024Huadong Medicine's Ustekinumab Biosimilar HDM3001 Receives Approval
  • 11/5/2024Photocure's Hexvix Secures Approval in China for Bladder Cancer Diagno...
  • 11/5/2024Landmark Whistleblower Program for China's Healthcare Sector: Proposed...
  • 11/4/2024Probe of AstraZeneca Executive in China Raises Questions about Company...
  • 11/4/2024How AstraZeneca Bilked China's Insurance Program Out of CNY Millions (...
  • 11/4/2024Big Pharma Doubles Down on China (The Wire China)
  • 11/4/2024HuidaGene Receives the First-Ever FDA Clearance of CRISPR/Cas13 RNA-Ed...
  • 11/4/2024US FDA Accepts BLA for HLX14, Biosimilar Candidate of PROLIA/XGEVA
  • 11/4/2024China Targets AstraZeneca in BMI Fraud Probe over Tagrisso
  • 11/4/2024BIOSECURE Act May Shift Biopharma Manufacturing from China to India, S...
  • 11/4/2024The 10th Round of National Level VBP of Drugs Officially Initiated wit...
  • 11/4/2024NMPA Signs Letter of Intent on Cooperation with Danish Medicines Agenc...
  • 11/1/2024Merck Faces Gardasil Sales Challenges in China, Impact Expected to Con...
  • 11/1/2024NMPA Issues Announcement for Applicability of ICH Guideline M12
  • Page:16/356 Total number of articles:10656: [First][<<] [14] [15] [16] [17] [18] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group